Qin Guijun, Zhou Yingni, Guo Feng, Ren Lei, Wu Lina, Zhang Yuanyuan, Ma Xiaojun, Wang Qingzhu
Department of Endocrinology (G.Q., Y.Zho., F.G., L.R., L.W., Y.Zha., X.M., Q.W.), The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China; and Institute of Clinical Medicine (Y.Zho., F.G., L.W., Y.Zha.), The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Mol Endocrinol. 2015 Jul;29(7):1080-91. doi: 10.1210/me.2014-1372. Epub 2015 Jun 1.
The dysfunction of mesangial cells (MCs) in high-glucose (HG) conditions plays pivotal role in inducing glomerular sclerosis by causing the imbalance between generation and degradation of extracellular matrix (ECM) proteins, which ultimately leads to diabetic nephropathy. This study was designed to determine the function of forkhead box protein O1 (FoxO1), an important transcription factors in regulating cell metabolism and oxidative stress, in MCs in HG conditions. Up-regulation of fibronectin, collagen type IV, and plasminogen activator inhibitor (PAI-1) was observed under HG conditions in vivo and in vitro, accompanied with elevation of protein kinase B (Akt) phosphorylation and reduction of FoxO1 bioactivity. After overexpression of constitutively active (CA) FoxO1 in vivo and in vitro by using lentivirus vector, in vivo and in vitro, FoxO1 expression and activity was increased, in accordance with up-regulation of antioxidative genes (catalase and superoxide dismutase, leading to alleviated oxidative stress as well as attenuated Akt activity, whereas overexpression of wild type-FoxO1 only expressed partial effect. Moreover, CA-FoxO1 decreased the expression of fibronectin, collagen type IV, and PAI-1, causing amelioration of renal pathological changes and decrease of ECM protein deposition in glomerulus. Overexpression of CA-FoxO1 in renal cortex also decreased activin type-I receptor-like kinase-5 levels and increased signaling mothers against decapentaplegic (Smad) 7 levels, and simultaneously inhibited Smad3 phosphorylation. Results from in vitro study indicated that increased combination of FoxO1 and Smad3 may interfere with the function of Smad3, including Smad3 phosphorylation and translocation, interaction with cAMP response element binding protein (CREB)-binding protein, and binding with PAI-1 promoter. Together, our findings shed light on the novel function of FoxO1 in inhibiting ECM deposition, which is beneficial to ameliorate MC dysfunction.
在高糖(HG)条件下,系膜细胞(MCs)功能障碍通过导致细胞外基质(ECM)蛋白生成与降解失衡,在诱导肾小球硬化中起关键作用,最终导致糖尿病肾病。本研究旨在确定叉头框蛋白O1(FoxO1)在HG条件下MCs中的功能,FoxO1是调节细胞代谢和氧化应激的重要转录因子。在体内和体外HG条件下均观察到纤连蛋白、IV型胶原和纤溶酶原激活物抑制剂(PAI-1)上调,同时蛋白激酶B(Akt)磷酸化升高,FoxO1生物活性降低。通过慢病毒载体在体内和体外过表达组成型激活(CA)FoxO1后,体内和体外FoxO1表达及活性均增加,抗氧化基因(过氧化氢酶和超氧化物歧化酶)上调,导致氧化应激减轻以及Akt活性减弱,而野生型FoxO1过表达仅表现出部分作用。此外,CA-FoxO1降低了纤连蛋白、IV型胶原和PAI-1的表达,改善了肾脏病理变化,减少了肾小球中ECM蛋白沉积。在肾皮质中过表达CA-FoxO1还降低了激活素I型受体样激酶5水平,增加了抗五聚体蛋白3(Smad)7水平,同时抑制了Smad3磷酸化。体外研究结果表明,FoxO1与Smad3结合增加可能会干扰Smad3的功能,包括Smad3磷酸化和易位、与环磷酸腺苷反应元件结合蛋白(CREB)结合蛋白的相互作用以及与PAI-1启动子的结合。总之,我们的研究结果揭示了FoxO1在抑制ECM沉积方面的新功能,这有利于改善MC功能障碍。